23.04.2014 - In one of several deals announced just after Easter, Swiss drugmaker Novartis said it would sell its animal health arm to U.S. rival Eli Lilly for about $5.4 billion. Lilly said...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)